Cargando…

Large-scale Metabolomic Analysis Reveals Potential Biomarkers for Early Stage Coronary Atherosclerosis

Coronary atherosclerosis (CAS) is the pathogenesis of coronary heart disease, which is a prevalent and chronic life-threatening disease. Initially, this disease is not always detected until a patient presents with seriously vascular occlusion. Therefore, new biomarkers for appropriate and timely dia...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gao, Xueqin, Ke, Chaofu, Liu, Haixia, Liu, Wei, Li, Kang, Yu, Bo, Sun, Meng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5603568/ https://www.ncbi.nlm.nih.gov/pubmed/28924163 http://dx.doi.org/10.1038/s41598-017-12254-1

Ejemplares similares

Author Correction: Large-scale Metabolomic Analysis Reveals Potential Biomarkers for Early Stage Coronary Atherosclerosis
por: Gao, Xueqin, et al.
Publicado: (2018)

Use of Plasma Metabolomics to Identify Diagnostic Biomarkers for Early Stage Epithelial Ovarian Cancer
por: Fan, Lijun, et al.
Publicado: (2016)

Large-scale gene analysis of rabbit atherosclerosis to discover new biomarkers for coronary artery disease
por: Yu, Xiaolan, et al.
Publicado: (2019)

Large-scale Metabolomic Profiling Identifies Novel Biomarkers for Incident Coronary Heart Disease
por: Ganna, Andrea, et al.
Publicado: (2014)

Identification of Novel Biomarkers for Early Diagnosis of Atherosclerosis Using High-Resolution Metabolomics
por: Sardar, Syed Wasim, et al.
Publicado: (2023)

Large-scale plasma metabolome analysis reveals alterations in HDL metabolism in migraine
por: Onderwater, Gerrit L.J., et al.
Publicado: (2019)

Topography of immune cell infiltration in different stages of coronary atherosclerosis revealed by multiplex immunohistochemistry
por: Cortenbach, Kimberley R.G., et al.
Publicado: (2022)

Plasma metabolomics reveals a potential panel of biomarkers for early diagnosis in acute coronary syndrome
por: Laborde, Carlos M., et al.
Publicado: (2013)

Large-Scale Non-Targeted Metabolomics Reveals Antioxidant, Nutraceutical and Therapeutic Potentials of Sorghum
por: Ramalingam, Ajay Prasanth, et al.
Publicado: (2021)

Application of metabolomics in the diagnosis of breast cancer: a systematic review
por: Yang, Liqing, et al.
Publicado: (2020)

Network of Interactions Between Gut Microbiome, Host Biomarkers, and Urine Metabolome in Carotid Atherosclerosis
por: Li, Rui-Jun, et al.
Publicado: (2021)

Endometrium metabolomic profiling reveals potential biomarkers for diagnosis of endometriosis at minimal-mild stages
por: Li, Jingjie, et al.
Publicado: (2018)

Update on Biomarkers Associated with Large-Artery Atherosclerosis Stroke
por: Rosário, Madalena, et al.
Publicado: (2023)

Personalized Early-Warning Signals during Progression of Human Coronary Atherosclerosis by Landscape Dynamic Network Biomarker
por: Ge, Jing, et al.
Publicado: (2020)

Large‐Scale Metabolomics and the Incidence of Cardiovascular Disease
por: Lind, Lars, et al.
Publicado: (2023)

Circulating sortilin level as a potential biomarker for coronary atherosclerosis and diabetes mellitus
por: Oh, Tae Jung, et al.
Publicado: (2017)

Metabolomic analyses reveal new stage-specific features of COVID-19
por: Jia, Hongling, et al.
Publicado: (2022)

Intra-Section Analysis of Human Coronary Arteries Reveals a Potential Role for Micro-Calcifications in Macrophage Recruitment in the Early Stage of Atherosclerosis
por: Chatrou, Martijn L. L., et al.
Publicado: (2015)

Coronary tortuosity is negatively correlated with coronary atherosclerosis
por: Li, Yang, et al.
Publicado: (2018)

Identification of Potential Ferroptosis-Related Biomarkers and Immune Infiltration in Human Coronary Artery Atherosclerosis
por: Liu, Hui, et al.
Publicado: (2022)

The Effect of Blood Pressure Variability on Coronary Atherosclerosis Plaques
por: Liu, Yue, et al.
Publicado: (2022)

Serum Metabolomic Profiling Reveals Biomarkers for Early Detection and Prognosis of Esophageal Squamous Cell Carcinoma
por: Wang, Pan Pan, et al.
Publicado: (2022)

Global metabolomics reveals potential urinary biomarkers of esophageal squamous cell carcinoma for diagnosis and staging
por: Xu, Jing, et al.
Publicado: (2016)

Correction to: Endometrium metabolomic profiling reveals potential biomarkers for diagnosis of endometriosis at minimal-mild stages
por: Li, Jingjie, et al.
Publicado: (2019)

Discovery of plasma biomarkers for predicting the severity of coronary artery atherosclerosis by quantitative proteomics
por: Ku, Eu Jeong, et al.
Publicado: (2020)

Integration of global metabolomics and lipidomics approaches reveals the molecular mechanisms and the potential biomarkers for postoperative recurrence in early-stage cholangiocarcinoma
por: Padthaisong, Sureerat, et al.
Publicado: (2021)

Application of Metabolomics to Identify Potential Biomarkers for the Early Diagnosis of Coronary Heart Disease
por: Jiang, Huali, et al.
Publicado: (2021)

Machine learning based on metabolomics reveals potential targets and biomarkers for primary Sjogren’s syndrome
por: Wang, Kai, et al.
Publicado: (2022)

Transcriptome-wide association study reveals novel susceptibility genes for coronary atherosclerosis
por: Zhao, Qiuping, et al.
Publicado: (2023)

(1)H-NMR spectroscopy identifies potential biomarkers in serum metabolomic signatures for early stage esophageal squamous cell carcinoma
por: Liu, Yan-Yan, et al.
Publicado: (2019)

Metabolomic analyses for atherosclerosis, diabetes, and obesity
por: Du, Fuyong, et al.
Publicado: (2013)

NGAL and Metabolomics: The Single Biomarker to Reveal the Metabolome Alterations in Kidney Injury
por: Noto, A., et al.
Publicado: (2013)

Tenascin C: A Potential Biomarker for Predicting the Severity of Coronary Atherosclerosis
por: Gao, Wen, et al.
Publicado: (2019)

Development of large-scale metabolite identification methods for metabolomics
por: Mitchell, Joshua M, et al.
Publicado: (2014)

Metabolomics Reveals Metabolic Biomarkers of Crohn's Disease
por: Jansson, Janet, et al.
Publicado: (2009)

Metabolomics reveals biomarkers of opioid use disorder
por: Ghanbari, Reza, et al.
Publicado: (2021)

Reply on “Vitamin D and coronary atherosclerosis”
por: Lee, Ah-Young, et al.
Publicado: (2017)

Metabolomics analysis reveals serum biomarkers in patients with diabetic sarcopenia
por: Tan, Yuwei, et al.
Publicado: (2023)

Coronary Atherosclerosis Imaging
por: Henein, Michael Y., et al.
Publicado: (2020)

Role of neutrophils in different stages of atherosclerosis
por: Zhang, Xiaojing, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_uec6pm8n7o3rn4u9voltm3gsuc